CONCORD DRUGS LIMITED Share Price
BSE: 538965|Pharmaceuticals₹65.25
+₹1.25 (1.95%) As on 05 Sep, 2025 | 15:15 ISTCONCORD DRUGS LIMITED Stock Performance
Market cap  ₹64 Crs | Open ₹64.80 | Prev. Close ₹64.00 |
Circuit range ₹65.28 - ₹62.72 | Day range ₹64.79 - ₹65.25 | Year range ₹26.10 - ₹67.00 |
Volume 12,495 | Avg. traded ₹64.97 | Revenue (12m) ₹47 Crs |
About CONCORD DRUGS LIMITED
Concord Drugs Limited is an India-based pharmaceutical company. The Company's principal activity is to manufacture licensed drugs based on the formulations approved. The Company is focused on developing drug delivery systems, including multiple unit pellet system (MUPS), sustained release, and modified release pellets. It operates a Current Good Manufacturing Practice (cGMP) contract manufacturing formulation-fill-finish facility, offering a full spectrum of pharmaceutical development and manufacturing services for drug products. The Company's products include pharmaceutical ready to fill pellets, MUPS; tissue bio adhesive; injectables (small volume parenterals); oral solid dosages (tablets); oral solid dosages (capsules); liquid orals, and dry syrup (powder). It also offers hand sanitizers under the brand name, PROTON SAFE. It manufactures hand sanitizers on third party basis also. The Company's oral liquid dosage forms include solutions, syrups, and suspensions.
As of last trading day, CONCORD DRUGS LIMITED opened at ₹64.80 and last traded at ₹65.25, showing a rise of 1.25 points (1.95%) compared to the previous close of ₹64.00. During the session, the stock touched a high of ₹65.25 and a low of ₹64.79. The company's market capitalization now stands at ₹64 Crs, with a P/E ratio of 148.8 and a dividend yield of 0.00%.
05 September 2025 – CONCORD DRUGS LIMITED Share Price Update
As of last trading day, CONCORD DRUGS LIMITED opened at ₹64.80 and last traded at ₹65.25, showing a rise of 1.25 points (1.95%) compared to the previous close of ₹64.00. During the session, the stock touched a high of ₹65.25 and a low of ₹64.79. The company's market capitalization now stands at ₹64 Crs, with a P/E ratio of 148.8 and a dividend yield of 0.00%.CONCORD DRUGS LIMITED Share Price Chart
₹65.25+₹1.25 (1.95%)
Please wait...
CONCORD DRUGS LIMITED Key Indicators
P/E ratio 148.84 | P/B ratio 1.04 | ROE -- |
ROCE -- | Dividend yield -- | Debt/Equity ratio 0 |
EPS 0.3 |
CONCORD DRUGS LIMITED Financial Ratios
Operating profit margin0% | Net profit margin0% |
ROE0% | ROA0% |
ROCE0% |
Quick ratio0 | Current ratio0 |
Interest coverage0 | Asset turnover0.95 |
Debt to Equity0 |
P/E ratio148.84 | P/B ratio1.04 |
EV / EBITDA0 | |
Dividend yield0% |
CONCORD DRUGS LIMITED Revenue Statement
All values are in ₹ Crores (Cr)
Year  | Revenue  | Operating Profit | Net Profit |
|---|---|---|---|
Mar-25 | ₹45.26 | ₹0.69 | ₹0.34 |
Mar-24 | ₹44.93 | ₹0.63 | ₹0.47 |
Mar-23 | ₹52.09 | ₹1.25 | ₹0.99 |
Mar-22 | ₹59.06 | ₹2.25 | ₹1.59 |
CONCORD DRUGS LIMITED Cash Flow
All values are in ₹ Crores (Cr)
Year | Operating | Investing | Financing |
|---|---|---|---|
Mar-24 | ₹-1.01 | ||
Mar-23 | ₹-2.27 | ||
Mar-22 | ₹-2.44 |
CONCORD DRUGS LIMITED Balance Sheet
All values are in ₹ Crores (Cr)
Period | Total Asset | Total Liability |
|---|---|---|
Mar-24 | ₹58.81 | ₹58.81 |
Mar-23 | ₹58.23 | ₹58.23 |
Mar-22 | ₹56.45 | ₹56.45 |
CONCORD DRUGS LIMITED Share Price History
| Day | Open | Close | Change % |
|---|---|---|---|
20-Aug-25 | ₹49.98 | ₹49.10 | -1.76% |
19-Aug-25 | ₹51.00 | ₹49.98 | -2.00% |
18-Aug-25 | ₹51.00 | ₹51.00 | -2.00% |
14-Aug-25 | ₹53.00 | ₹52.04 | -2.00% |
13-Aug-25 | ₹53.64 | ₹53.10 | -1.01% |
12-Aug-25 | ₹52.57 | ₹53.64 | |
11-Aug-25 | ₹53.64 | ₹53.64 | -1.99% |
08-Aug-25 | ₹56.95 | ₹54.73 | -1.99% |
Stocks Similar to CONCORD DRUGS LIMITED
Stock Name | Price | Change % |
|---|---|---|
| OMKAR PHARMACHEM LTD | ₹25.56 | +0.00 (0.00%) |
| ORTIN LABORATORIES | ₹12.64 | -₹0.26 (-2.02%) |
| PANJON LTD | ₹19.06 | -₹0.76 (-3.83%) |
| SANJIVANI PARANTERAL LTD | ₹249.25 | -₹0.55 (-0.22%) |
| UNICK FIXA FORM AND PRINTERS | ₹70.10 | +₹1.74 (2.55%) |
Popular Stocks
Stock Name | Price | Change % |
|---|---|---|
| IDFC First Bank Share Price | ₹72.60 | +₹0.37 (0.51%) |
| Indian Oil Corp Share Price | ₹139.65 | -₹0.03 (-0.02%) |
| Jaiprakash Power Ventures Share Price | ₹19.07 | +₹0.90 (4.95%) |
| NHPC Share Price | ₹77.82 | -₹0.27 (-0.35%) |
| Suzlon Share Price | ₹57.87 | +₹0.45 (0.78%) |
| Tata Motors Share Price | ₹691.70 | +₹4.20 (0.61%) |
| Tata Power Share Price | ₹385.80 | +₹3.20 (0.84%) |
| Tata Steel Share Price | ₹167.68 | +₹0.87 (0.52%) |
| Vodafone Idea Share Price | ₹7.23 | +₹0.62 (9.38%) |
| YES Bank Share Price | ₹20.44 | +₹0.15 (0.74%) |
CONCORD DRUGS LIMITED News
CONCORD DRUGS LIMITED Share Price FAQs
What is the share price of CONCORD DRUGS LIMITED today?
CONCORD DRUGS LIMITED share price is ₹ 65.25 as on Sep, 2025 | 15:15 IST.
What are the high & low stock price of CONCORD DRUGS LIMITED today?
CONCORD DRUGS LIMITED stock price hit a high of ₹ 65.25 and low of ₹ 64.79 as on Sep, 2025 | 15:15 IST.
What is the market cap of CONCORD DRUGS LIMITED?
The market cap of CONCORD DRUGS LIMITED is ₹ 64.00 Crores as on Sep, 2025 | 15:15 IST.
What are the the 52-week high and low share prices of CONCORD DRUGS LIMITED stock on the NSE?
52-week high stock Price of CONCORD DRUGS LIMITED is ₹ 67.00 and Low Price is ₹ 26.10 as on Sep, 2025 | 15:15 IST.
What are the stock symbols of CONCORD DRUGS LIMITED?
The stock symbol of CONCORD DRUGS LIMITED is NSE: CONCORD on the NSE, BSE: 538965 on the BSE, and the ISIN is INE858L01010.
Can I buy CONCORD DRUGS LIMITED shares on Holidays?
No, shares of CONCORD DRUGS LIMITED or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell CONCORD DRUGS LIMITED shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
How to buy CONCORD DRUGS LIMITED shares?
To buy CONCORD DRUGS LIMITED shares,open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order
What is the PE and PB ratio of CONCORD DRUGS LIMITED?
The PE and PB ratio of CONCORD DRUGS LIMITED is 148.84 and 1.04 respectively, as on Sep, 2025 | 15:15 IST.
What are the returns on CONCORD DRUGS LIMITED shares?
The historical returns for CONCORD DRUGS LIMITED shares are 69.63 for 1 year, 137.04 for 3 year and 262.61 for 5 year.